Prognostic Value of Biomarkers in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy

Prognostic Value of Biomarkers in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy

Background: Immune checkpoint inhibitors (ICIs) have improved outcomes for several malignancies, but cancer patients face an increased risk of cardiovascular disease due to shared risk factors, similar biological mechanisms, and cardiotoxic side effects of therapy. Effective risk stratification stra...

Full description

Saved in:
Bibliographic Details
Main Authors: Christopher Mann, MD, Ulrike Pailer, MSc, Andreas Spannbauer, MD, Fardin Hamidi, MD, Aliza Veronika Braser, Martin Hülsmann, MD, Christian Gerges, MD, PhD, Michael Gottsauner-Wolf, MD, Mariann Gyöngyösi, MD, Markus Raderer, MD, Martin Riesenhuber, MD, PhD, Christian Hengstenberg, MD, Jutta Bergler-Klein, MD, Thomas A. Zelniker, MD, MSc
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:JACC: Advances
Subjects:
biomarkers
cardiotoxicity
cardiovascular hospitalization
immune checkpoint inhibitors
myocarditis
risk stratification
Online Access:http://www.sciencedirect.com/science/article/pii/S2772963X25004466
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2772963X25004466

Similar Items